This video series focuses on the key unmet needs in chronic myeloid leukaemia (CML). In this series we are joined by a host of international experts who provide their perspectives on resistance to tyrosine kinase inhibitors (TKIs), the impact of intolerance on patients and the potential consequences of sequential TKIs use. The series aims to shine a light on how healthcare professionals can...Show more

Rate this content: 
No votes yet
UK | June 2022 | 196112

Drawing on leading practitioner and academic insights, the following webinars are designed to inform and support the treatment and care of patients with chronic myeloid leukaemia (CML).Show more

Rate this content: 
No votes yet
UK | February 2022 | 188508
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]